1. INTRODUCTION {#sec1}
===============

Approximately 37 million people were living with HIV (PLHIV) by the end of 2017 (<http://www.unaids.org/>). A lot of different approaches, both behavioral and biomedical, have been used to reduce HIV transmission \[[@r1]\] but still around 2 million people are infected every year. The global community is now committed to end the HIV epidemic as a public health threat by 2030. UNAIDS has set the 90-90-90 target: 90% of all PLHIV to be aware of their HIV status (first 90); 90% of the HIV-diagnosed to receive antiretroviral treatment (ART) (second 90); and 90% of those on ART to achieve virological suppression (third 90).

Social network-based interventions to prevent HIV transmission have shown promising results \[[@r2]-[@r9]\]. The Transmission Reduction Intervention Project (TRIP) was a recently implemented network-based intervention to detect people who had acquired HIV in the past 6 months \[[@r10]\]. Identifying people with recent HIV infection is very

important. Increased HIV-RNA levels have been associated with heightened risk of HIV transmission \[[@r11]-[@r17]\]. Substantial reductions in HIV transmission or incidence have been observed or expected in settings with declines in individual or community viral load, respectively \[[@r12], [@r18]-[@r27]\]. Given that infectivity has been positively correlated with viral load, HIV transmission during the period of early infection (when viral load becomes very high) is extremely likely \[[@r28]-[@r41]\]. Phylogenetic studies estimate that almost half of the transmissions attributable to an HIV-infected person occur during the recent phase of his/her HIV infection \[[@r42]-[@r54]\].

Given the epidemiological associations described above, we aimed to investigate phylogenetically, using near full-length HIV sequences, whether HIV transmissions occur more frequently among persons with high viral load, which is a salient characteristic of recent HIV infection.

2. MATERIALS AND METHOD {#sec2}
=======================

2.1. Project Description {#sec2.1}
------------------------

TRIP was a multi-site (Athens, Greece; Chicago, United States; and Odessa, Ukraine), network-based contact-tracing intervention to detect individuals with recent and/or undiagnosed HIV infection and link them to care. Details regarding the design and implementation of TRIP in Athens have been described elsewhere \[[@r10]\]. TRIP, Athens recruited 356 individuals (90.2% people who inject drugs - PWID). Of these, 149 participants (46.4%) tested HIV positive \[[@r10]\]. Demographics, epidemiological and clinical characteristics of the HIV positive participants in TRIP are presented in Table **[1](#T1){ref-type="table"}**.

2.2. HIV-1 Testing {#sec2.2}
------------------

Blood samples were tested for HIV antibodies by AxSYM HIV-1/2 gO (Abbott) and confirmed by Western Blot (MP Diagnostics). Recent HIV-1 infection was determined using the Limiting Antigen Avidity assay \[[@r55]\]. HIV-RNA in plasma was quantified using Artus HI Virus-1 RT-PCR (Qiagen), according to the manufacturer's recommendations.

2.3. HIV-1 Sequencing and Subtyping {#sec2.3}
-----------------------------------

104 near full-length genomic sequences were generated using methods developed under the Infection Response through Virus Genomics (ICONIC) project \[[@r56], [@r57]\]. Nucleotide sequences were aligned using the HIVAlign tool available on the Los Alamos HIV sequence database (<http://hiv.lanl.gov/>).

HIV-1 subtypes were identified for 104 sequences using the online automated HIV-1 subtyping tool COMET v.0.2 (COntext-based Modeling for Expeditious Typing) (<http://comet.retrovirology.lu/>) and the REGA HIV-1 subtyping tool. Subtyping results were further confirmed by using references to perform phylogenetic analysis.

These references were representative of all known HIV-1 subtypes and of most of the Circulating Recombinant Forms (CRFs), and were available on the Los Alamos HIV-1 sequence database. The presence of recombination was tested by bootscanning analysis as implemented in Simplot v3.5.1 \[[@r58]\] using pure subtypes and CRFs as references. Bootscanning analysis was run for a sliding window of 400 bps moving in steps of 50 bps. Putative recombinants were confirmed by phylogenetic analysis in separate genomic fragments with discordant phylogenetic clustering. Tree visualization and annotation were done using the FigTree v1.4 program (<http://tree.bio.ed.ac.uk/software/figtree/>).

2.4. Hypothesis Testing {#sec2.4}
-----------------------

We performed phylogenetic analyses to examine whether transmissions occur more often among persons with high plasma HIV-RNA levels (10^6^ or 10^5^ IU/mL) \[[@r59]\], a marker of recent HIV infection. Phylogenetic analysis was performed using the maximum likelihood method (ML) under the Generalized Time Reversible (GTR) model of nucleotide substitution including a Gamma-distributed rate of heterogeneity among sites as implemented in RAxMLv8.0 \[[@r60]\] and FastTree v2.1 \[[@r61]\]. HIV-1 sequences that were found outside the local transmission networks (LTNs) of PWID \[[@r62]\] or the Unique Recombinant Forms (URFs) were excluded from the analysis. Short length sequences were also excluded (\< 4,000 bps). Phylogenetic trees were derived from non-recombinant near full-length genome alignments that belonged to the 4 PWID LTNs (CRF14_BG/B/CRF14_BG, CRF35_AD/A/ CRF35_AD, subtypes A and B).

We performed additional analysis to test whether transmissions among PWID with high HIV-RNA are frequent. The hypothesis that transmissions occur frequently among persons with high plasma HIV-RNA values (10^6^ or 10^5^ IU/mL) was investigated by reconstructing ancestral states assigned at the tips (high or low HIV-RNA values), and using the criterion of parsimony to estimate the total number of character changes across the phylogeny. In this case, character changes correspond to transmissions between persons with different levels of HIV-RNA ("low" and "high"). The analysis was performed on 300 bootstrap-reconstructed trees as estimated in RAxML version 8.0, using Mesquite program version 3.5 \[[@r63]\]. The estimated number of events corresponds to the "observed number of transmissions among persons with different HIV-RNA values". The null hypothesis that corresponds to a random distribution of the characters states at the tips was simulated after a random reshuffling of the characters on the full set of bootstrap trees.

We also tested if HIV sequences from persons with high viral loads (\>10^6^ IU/mL) formed significant phylogenetic clusters receiving Shimodaira-Hasegawa (SH) value \> 0.9 or bootstrap support \> 75%.

2.5. Statistical Analysis {#sec2.5}
-------------------------

The non-parametric, one-sided Mann-Whitney test was used to compare the distribution of the total number of character changes (transmissions between different groups of HIV-RNA) between the original bootstrap trees and the trees that were randomly reshuffled at the tips (STATA 14 - StataCorp LP).

3. RESULTS {#sec3}
==========

HIV-1 subtyping and recombination analysis showed that sequences from 63 individuals (60.6%) ([Table 1](#T1){ref-type="table"}) fell within the LTNs of PWID: CRF14_BG/B/CRF14_BG (n=35, 33.7%); CRF35_AD/A/CRF35_AD (n=17, 16.3%); subtype B (n=8, 7.7%); subtype A (n=3, 2.9%). The rest of the sequences were classified as subtypes A (n=4, 3.8%) and B (n=1, 1%) that did not belong to PWID-LTN, and as URFs (n=36, 34.6%). HIV-1 sequences available in protease (PR) and partial reverse transcriptase (RT) that were classified initially as CRF35_AD and CRF14_BG \[[@r62],[@r64]\], were later identified as unique recombinants with identical patterns (CRF35_AD/A/CRF35_AD and CRF14_BG/B/CRF14_BG, respectively, in their complete genome).

Phylogenetic analysis using the 62 near-complete HIV-1 sequences that belonged to the 4 PWID-LTNs (CRF14\_ BG/B/CRF14_BG, CRF35_AD/A/CRF35_AD, subtypes A and B) was conducted to investigate whether transmissions occur more often among individuals with high HIV-RNA levels. One sequence was excluded due to its short length (\< 4,000 bps). Phylogenetic trees that were inferred using the 62 sequences are shown in [Fig. (**[1](#F1){ref-type="fig"}**)](#F1){ref-type="fig"}. The sequences from persons with high HIV-RNA (\> 10^5^ IU/mL or \> 10^6^ IU/mL) are highlighted in different colors (Figs. **[1A](#F1){ref-type="fig"}** and **[1B](#F1){ref-type="fig"}**).

Additional analyses included the estimation of the total number of character changes between PWID with high and low HIV-RNA, which are indicative of transmissions between these two groups, and the examination of whether the number of transmissions is significantly lower than the number of changes expected by chance. For both HIV-RNA cut-offs (10^5^ and 10^6^ IU/mL), the number of transmissions between the two groups was significantly lower (p\<0.001), suggesting that HIV transmissions occur more frequently between PWID with similar levels of HIV-RNA (Figs. **[2A](#F2){ref-type="fig"}** and **[2B](#F2){ref-type="fig"}**). Notably, most sequences from PWID with HIV-RNA \> 10^6^ IU/mL formed highly supported clusters (*i.e.*, they received SH-support \> 0.9 or bootstrap support \> 75%) (Fig. **[1B](#F1){ref-type="fig"}**). For 14 of 18 PWID with HIV-RNA \> 10^6^ IU/mL, phylogenetic clustering with at least one sequence was highly supported. 10 of the 14 sequences (71.4%) from PWID with HIV-RNA \> 10^6^ IU/mL were clustered in 5 pairs (Fig. **[1B](#F1){ref-type="fig"}**).

We also examined whether there were any PWID with documented recent infection (\< 6 months) among the PWID with HIV-RNA \> 10^6^ IU/mL. For 4 of the 5 clusters (80%) of sequences (n=10) from PWID with high HIV- RNA, there was in each cluster at least one sequence from a recently HIV-infected PWID (Fig. **[1C](#F1){ref-type="fig"}**). Specifically, 6 of 10 transmissions (60%) among PWID with HIV-RNA \> 10^6^ IU/mL in transmission pairs originated from people with recent HIV infection. For one cluster, both sequences were from recently HIV-infected individuals (Fig. **[1C](#F1){ref-type="fig"}**).

4. DISCUSSION {#sec4}
=============

This study examined, using molecular epidemiology methods, whether HIV transmissions occur more often among PWID with high HIV-RNA levels. Our analysis was based on near full-length genomic sequencing from HIV-infected PWID who participated in a network-based intervention (TRIP) in Athens, Greece. All analyses supported that transmissions among PWID with high HIV-RNA levels (\> 10^5^ IU/mL or \> 10^6^ IU/mL) occur at high rates. Given that very high HIV-RNA levels (\> 10^6^ IU/mL) are a marker for recent HIV infection, our results suggest that transmissions among people who acquired HIV recently are more frequent. The important role of recently HIV-infected individuals was further supported by our findings that in 80% of the clusters of PWID with HIV-RNA \> 10^6^ IU/mL, there was at least one PWID with documented recent infection. This suggests that those individuals who have recently been infected with HIV may be the source of HIV transmission within transmission pairs.

These findings are in accordance with those from other analyses in TRIP and also with evidence from previous studies. It has been shown in TRIP that the proportion of recently HIV-infected persons among the HIV positives in the networks of recently HIV-infected seeds was approximately 3 times the proportion of recently HIV-infected persons in the networks of seeds with long-term HIV infection \[[@r10]\]. Seeds refer to primary participants recruited by TRIP to start the network-based intervention. Brenner *et al.* have reported that almost 50% of viral sequences from primary infections in Quebec, Canada were clustered into groups of 2-17 sequences/cluster \[[@r43]\]. Pinkerton used mathematical modeling to show that the probability of HIV transmission during acute infection was approximately 42 times higher than that during chronic HIV infection \[[@r65]\]. The same analysis revealed that the acute phase was responsible for 89% of all transmission events in the first 20 months of follow-up \[[@r65]\]. Miller *et al.* also highlighted the important role of acute and early HIV infection (due to high levels of HIV-RNA during these stages), as opposed to chronic infection, in sexual transmission \[[@r66]\]. Similarly, several studies reported that during HIV outbreaks among PWID, a high number of individuals have been infected with genetically similar viruses \[[@r62], [@r64], [@r67]-[@r80]\] - a finding that supports the hypothesis of the involvement of recently HIV-infected people in HIV transmissions. The crucial role of the natural history of HIV-1 (high HIV-RNA) has also been investigated by simulation studies and was found to play a significant role (along with injection risk networks) during periods of high HIV prevalence among PWID \[[@r5]\].

CONCLUSION
==========

In the current study, using molecular epidemiology methods, we generated additional evidence that transmissions were more likely to have occurred among PWID who had high HIV-RNA at the time the study was conducted. We also found that in 80% of the transmission pairs of PWID with very high viral load, there was at least one recent infection.

Given these findings, early diagnosis soon after infection and immediate treatment initiation to reduce viral load should receive attention as a major HIV prevention strategy.
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###### 

Demographics, epidemiological and clinical characteristics of: i) HIV-infected participants (N=149) of the Transmission Reduction Intervention Project (TRIP) and ii) a subset of the HIV positives (N=63 of 149) who were in local transmission networks of PWID in Athens, Greece.

  **Characteristics**                                                       **HIV Positives in TRIP**   **HIV Positives in PWID-LTNs**
  ----------------------------------------------------- ------------------- --------------------------- --------------------------------
  Total \[Ν (%)\]                                                           149 (100)                   63 (100)
  Gender \[Ν (%)\]                                      Males               113 (75.8)                  49 (77.8)
                                                        Females             36 (24.2)                   14 (22.2)
  Median age \[years (IQR)\]                                                34 (30-40)                  34 (30-39)
  Education level \[Ν (%)\]                             Up to high school   131 (87.9)                  59 (93.7)
                                                        Above high school   18 (12.1)                   4 (6.3)
  Accommodation status in the past 6 months \[Ν (%)\]   Non-homeless        97 (65.1)                   42 (66.7)
                                                        Homeless            52 (34.9)                   21 (33.3)
  Drug injection in last 6 months \[Ν (%)\]^a,\ b^      Non- PWID           5 (3.4)                     2 (3.2)
                                                        PWID                141 (96.6)                  60 (96.8)
  Duration of injection \[years (IQR)\]^c,\ d^                              13 (7-17)                   12.5 (7-17)
  HIV-RNA \[log IU/ml (IQR)\]^e^                                            5.4 (4.5-6.1)               5.5 (5.0-6.1)

IQR, interquartile range; PWID, people who inject drugs; ^a^Ν=146 (of 149 HIV positives); ^b^Ν=62 (of 63 HIV positives); ^c^N= 140 (of 149 HIV positives); ^d^Ν=60 (of 63 HIV positives); ^e^N= 126 (of 149 HIV positives).
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